Sustained Scalp, Eyebrow, and Eyelash Hair Regrowth with Ritlecitinib Through Week 48 in Patients with Alopecia Areata: Post-Hoc Analysis of the ALLEGRO Phase 2b/3 Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 6, p. s293, 2023. DOI: 10.25251/skin.7.supp.293. Disponível em: https://skin.dermsquared.com/skin/article/view/2414. Acesso em: 18 apr. 2026.